Investigador Principal: LUIS ÁLVAREZ-VALLINA
Financiación:
Fundación Mutua Madrileña
Multivalent and multispecific angiogenesis inhibitors consisting of antibody fragments and oligomeric forms of collagen XVIII Duración: 2005-2007
IP: Luis Álvarez-Vallina
Ministerio de Ciencia y Tecnología
Plan Nacional de I+D+I (2004-2007) Programa Nacional de Biotecnología (BIO2005-04794): Therapeutic Stem Cells Duration: 2006-2008
IP: Luis Álvarez-Vallina
Patentes:
Álvarez-Vallina. L., Agha-Mohammadi, S. & Russell, S.J.
Improvements in or relating to expression of immunogeneic substances
(WO 99/12574).
Álvarez-Vallina. L. & Russell, S.J.
Improvements in or relating to regulation of T cell activation
(WO 99/12573).
Álvarez-Vallina, L., Sanz Alcober, L., Pascual Carrasco, M., Muñoz Carreo, A., González de Mingo, M. & Hernández Salvador, C.
Method for in vitro evaluation of a large scale of biological activity of compounds under relevant physiological or pathological conditions.
(PCT/ES02/00327)
Álvarez-Vallina, L., Sánchez-Arévalo Lobo VJ, Cuesta AM, Sanz L, Compte M.
Multivalent and multispecific angiogenesis inhibitors consisting of antibody fragments and oligomeric forms of collagen XVIII
(PCT/EP2005/011714).
